Park Avenue Compounding is recalling 858 syringes of Phenylephrine HCI (1000 mcg / 10 mL) due to deviations from Current Good Manufacturing Practice (CGMP) requirements. These injectable syringes were distributed in Missouri and were found to have quality control issues that could affect the safety and effectiveness of the medication. Consumers and healthcare facilities should immediately identify and isolate the affected lot to prevent further use.
Failure to follow proper manufacturing practices for injectable drugs can lead to potential sterility issues or incorrect potency, which may cause serious health complications for patients receiving the medication.
Quantity: 858 syringes affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.